Cite
HARVARD Citation
Zecchin, D. et al. (2020). Combined targeting of G protein‐coupled receptor and EGF receptor signaling overcomes resistance to PI3K pathway inhibitors in PTEN‐null triple negative breast cancer. EMBO molecular medicine. 12 (8), p. n/a. [Online].